The PORTOLA Clinical Trial: Investigating a New Path for Treating AIH
Автор: Autoimmune Hepatitis
Загружено: 2023-11-27
Просмотров: 390
Описание:
In this session, Li Long, M.D., Ph.D., Vice President of Clinical Development for Kezar Life Sciences, introduces PORTOLA, a phase 2a clinical trial evaluating Kezar Life Sciences’ investigational drug, zetomipzomib (KZR-616), as a potential new treatment for autoimmune hepatitis, addressing the importance of clinical trial participation and meeting the unmet needs of people living with AIH.
Zetomipzomib (KZR-616) is an investigational product and has not been approved for commercial use in the United States or any other country for any indication.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: